We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PAR, ADVANCIS AGREE TO DEVELOP NEW BRAND DRUG
PAR, ADVANCIS AGREE TO DEVELOP NEW BRAND DRUG
June 4, 2004
Brand drugmaker Advancis Pharmaceutical and generic firm Par Pharmaceutical last week finalized an agreement to develop and co-promote a new brand version of the widely used generic antibiotic amoxicillin.